Authors of the work during the national multicenter study of immune monitoring of vaccination
The researchers used an mRNA vaccine like Pfizer's because it may be effective against all pathogens in this group.
In order to test this, the authors compared the immune response in eight people who had survived SARS, ten who had recovered from COVID-19, and another ten healthy people.
As a result of the analysis, it turned out that beforevaccination, survivors of SARS did not develop antibodies to SARS-CoV-2, however, after receiving two doses of the mRNA vaccine, everyone began to develop antibodies that could resist not only COVID-19, but also SARS-CoV-1 and other animal coronaviruses, transmitted to humans.
We have studied the possibility of induction of neutralizingantibodies that can block the normal interaction of the virus with the human ACE2 receptor, which will provide protection not only against all known and unknown variants of SARS-CoV-2, but also against future sarbecoviruses.
Chi-Wa Tan, doctor and first author of the article
Now scientists are conducting experiments to create third-generation vaccines that will fight all coronaviruses.
Read more:
Giant iceberg A74 collides with the coast of Antarctica
Two new dinosaur species discovered in China
What is the Kessler effect, and also when and what will the collision of satellites in orbit lead to?